These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 27065006)

  • 1. Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats.
    Bruijnzeel AW; Qi X; Guzhva LV; Wall S; Deng JV; Gold MS; Febo M; Setlow B
    PLoS One; 2016; 11(4):e0153327. PubMed ID: 27065006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response effects of systemic anandamide administration in mice sequentially submitted to the open field and elevated plus-maze tests.
    Ribeiro A; Ferraz-de-Paula V; Pinheiro ML; Palermo-Neto J
    Braz J Med Biol Res; 2009 Jun; 42(6):556-60. PubMed ID: 19448906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and Pharmacodynamic Characterization of Tetrahydrocannabinol-Induced Cannabinoid Dependence After Chronic Passive Cannabis Smoke Exposure in Rats.
    Ravula A; Chandasana H; Jagnarine D; Wall SC; Setlow B; Febo M; Bruijnzeel AW; Derendorf H
    Cannabis Cannabinoid Res; 2019; 4(4):240-254. PubMed ID: 32042924
    [No Abstract]   [Full Text] [Related]  

  • 4. Cannabis: discrimination of "internal bliss"?
    Wiley JL
    Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of AM1346, a high-affinity CB1 receptor selective anandamide analog, on open-field behavior in rats.
    Järbe TU; DiPatrizio NV; Li C; Makriyannis A
    Behav Pharmacol; 2007 Nov; 18(7):673-80. PubMed ID: 17912052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats.
    Braida D; Limonta V; Malabarba L; Zani A; Sala M
    Eur J Pharmacol; 2007 Jan; 555(2-3):156-63. PubMed ID: 17116299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates.
    Kangas BD; Leonard MZ; Shukla VG; Alapafuja SO; Nikas SP; Makriyannis A; Bergman J
    J Pharmacol Exp Ther; 2016 Apr; 357(1):125-33. PubMed ID: 26826191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function.
    Romero J; de Miguel R; García-Palomero E; Fernández-Ruiz JJ; Ramos JA
    Brain Res; 1995 Oct; 694(1-2):223-32. PubMed ID: 8974649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons.
    Romero J; García L; Cebeira M; Zadrozny D; Fernández-Ruiz JJ; Ramos JA
    Life Sci; 1995; 56(23-24):2033-40. PubMed ID: 7776829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance.
    Mallet PE; Beninger RJ
    Life Sci; 1998; 62(26):2431-9. PubMed ID: 9651110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocannabinoid system as a target for the treatment of cannabis dependence.
    Clapper JR; Mangieri RA; Piomelli D
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):235-43. PubMed ID: 18691603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological activity of inhalation exposure to marijuana smoke in mice.
    Lichtman AH; Poklis JL; Poklis A; Wilson DM; Martin BR
    Drug Alcohol Depend; 2001 Jul; 63(2):107-16. PubMed ID: 11376914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
    Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
    Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties.
    Panagis G; Vlachou S; Nomikos GG
    Curr Drug Abuse Rev; 2008 Nov; 1(3):350-74. PubMed ID: 19630731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use.
    Leweke FM; Giuffrida A; Koethe D; Schreiber D; Nolden BM; Kranaster L; Neatby MA; Schneider M; Gerth CW; Hellmich M; Klosterkötter J; Piomelli D
    Schizophr Res; 2007 Aug; 94(1-3):29-36. PubMed ID: 17566707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
    Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray.
    Moreira FA; Aguiar DC; Guimarães FS
    Neuropharmacology; 2007 Mar; 52(3):958-65. PubMed ID: 17156799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.